new BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 13 hits with Last Name = 'dürr' and Initial = 'h'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Neuropeptide Y receptor type 2


(Homo sapiens (Human))
BDBM50015490
PNG
(CHEMBL438945 | H-YPSKPDNPGEDAPAEDMARYYSALRHYINLITR...)
Show InChI InChI=1S/C189H285N55O57S/c1-15-93(7)148(179(295)234-128(81-140(193)254)168(284)226-123(74-92(5)6)171(287)239-149(94(8)16-2)180(296)240-150(99(13)247)181(297)222-115(31-22-67-208-189(202)203)156(272)220-117(56-59-139(192)253)161(277)218-113(29-20-65-206-187(198)199)157(273)224-121(151(195)267)76-101-38-48-107(249)49-39-101)238-172(288)126(79-104-44-54-110(252)55-45-104)229-167(283)127(80-105-86-204-90-210-105)230-159(275)114(30-21-66-207-188(200)201)219-164(280)122(73-91(3)4)225-154(270)96(10)212-173(289)133(88-245)236-166(282)125(78-103-42-52-109(251)53-43-103)228-165(281)124(77-102-40-50-108(250)51-41-102)227-158(274)112(28-19-64-205-186(196)197)216-152(268)95(9)211-155(271)119(62-72-302-14)221-169(285)130(84-146(263)264)232-162(278)118(58-61-144(259)260)217-153(269)97(11)213-176(292)136-33-24-68-241(136)182(298)98(12)214-163(279)129(83-145(261)262)231-160(276)116(57-60-143(257)258)215-142(256)87-209-175(291)135-32-23-70-243(135)185(301)132(82-141(194)255)235-170(286)131(85-147(265)266)233-177(293)138-35-26-71-244(138)184(300)120(27-17-18-63-190)223-174(290)134(89-246)237-178(294)137-34-25-69-242(137)183(299)111(191)75-100-36-46-106(248)47-37-100/h36-55,86,90-99,111-138,148-150,245-252H,15-35,56-85,87-89,190-191H2,1-14H3,(H2,192,253)(H2,193,254)(H2,194,255)(H2,195,267)(H,204,210)(H,209,291)(H,211,271)(H,212,289)(H,213,292)(H,214,279)(H,215,256)(H,216,268)(H,217,269)(H,218,277)(H,219,280)(H,220,272)(H,221,285)(H,222,297)(H,223,290)(H,224,273)(H,225,270)(H,226,284)(H,227,274)(H,228,281)(H,229,283)(H,230,275)(H,231,276)(H,232,278)(H,233,293)(H,234,295)(H,235,286)(H,236,282)(H,237,294)(H,238,288)(H,239,287)(H,240,296)(H,257,258)(H,259,260)(H,261,262)(H,263,264)(H,265,266)(H4,196,197,205)(H4,198,199,206)(H4,200,201,207)(H4,202,203,208)/t93-,94-,95-,96-,97-,98-,99+,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,148-,149-,150-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
n/an/a 0.5n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Compound was evaluated for its inhibitory activity against Y2 receptor of rabbit kidney membrane


Bioorg Med Chem Lett 3: 937-942 (1993)


Article DOI: 10.1016/S0960-894X(00)80696-4
BindingDB Entry DOI: 10.7270/Q2H9954N
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 2


(Homo sapiens (Human))
BDBM50281776
PNG
(Ac-RHYIN-(Cha)-(Cha)-TRQRY | CHEMBL268351)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O
Show InChI InChI=1S/C79H123N25O19/c1-5-41(2)61(101-70(116)55(35-44-22-26-49(107)27-23-44)97-69(115)56(37-48-39-88-40-92-48)98-65(111)51(93-43(4)106)19-12-32-89-77(82)83)72(118)99-57(38-60(81)110)71(117)103-63(46-15-8-6-9-16-46)75(121)104-64(47-17-10-7-11-18-47)74(120)102-62(42(3)105)73(119)96-53(21-14-34-91-79(86)87)66(112)95-54(30-31-59(80)109)68(114)94-52(20-13-33-90-78(84)85)67(113)100-58(76(122)123)36-45-24-28-50(108)29-25-45/h22-29,39-42,46-47,51-58,61-64,105,107-108H,5-21,30-38H2,1-4H3,(H2,80,109)(H2,81,110)(H,88,92)(H,93,106)(H,94,114)(H,95,112)(H,96,119)(H,97,115)(H,98,111)(H,99,118)(H,100,113)(H,101,116)(H,102,120)(H,103,117)(H,104,121)(H,122,123)(H4,82,83,89)(H4,84,85,90)(H4,86,87,91)/t41-,42+,51-,52-,53-,54-,55-,56-,57-,58-,61-,62-,63-,64-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
n/an/a 3n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Compound was evaluated for its inhibitory activity against human neuropeptide Y2 receptor expressing LN319 cells


Bioorg Med Chem Lett 3: 937-942 (1993)


Article DOI: 10.1016/S0960-894X(00)80696-4
BindingDB Entry DOI: 10.7270/Q2H9954N
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 2


(Homo sapiens (Human))
BDBM50281775
PNG
(Ac-RHYINL-(Cha)-TRQRY | CHEMBL414482)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O
Show InChI InChI=1S/C77H121N25O19/c1-7-40(4)60(100-70(116)54(33-43-19-23-47(105)24-20-43)96-67(113)55(35-46-37-86-38-90-46)97-63(109)49(91-42(6)104)16-11-29-87-75(80)81)71(117)98-56(36-59(79)108)68(114)95-53(32-39(2)3)69(115)102-62(45-14-9-8-10-15-45)73(119)101-61(41(5)103)72(118)94-51(18-13-31-89-77(84)85)64(110)93-52(27-28-58(78)107)66(112)92-50(17-12-30-88-76(82)83)65(111)99-57(74(120)121)34-44-21-25-48(106)26-22-44/h19-26,37-41,45,49-57,60-62,103,105-106H,7-18,27-36H2,1-6H3,(H2,78,107)(H2,79,108)(H,86,90)(H,91,104)(H,92,112)(H,93,110)(H,94,118)(H,95,114)(H,96,113)(H,97,109)(H,98,117)(H,99,111)(H,100,116)(H,101,119)(H,102,115)(H,120,121)(H4,80,81,87)(H4,82,83,88)(H4,84,85,89)/t40-,41+,49-,50-,51-,52-,53-,54-,55-,56-,57-,60-,61-,62-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
n/an/a 5n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Compound was evaluated for its inhibitory activity against human neuropeptide Y2 receptor expressing LN319 cells


Bioorg Med Chem Lett 3: 937-942 (1993)


Article DOI: 10.1016/S0960-894X(00)80696-4
BindingDB Entry DOI: 10.7270/Q2H9954N
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 2


(Homo sapiens (Human))
BDBM50281776
PNG
(Ac-RHYIN-(Cha)-(Cha)-TRQRY | CHEMBL268351)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O
Show InChI InChI=1S/C79H123N25O19/c1-5-41(2)61(101-70(116)55(35-44-22-26-49(107)27-23-44)97-69(115)56(37-48-39-88-40-92-48)98-65(111)51(93-43(4)106)19-12-32-89-77(82)83)72(118)99-57(38-60(81)110)71(117)103-63(46-15-8-6-9-16-46)75(121)104-64(47-17-10-7-11-18-47)74(120)102-62(42(3)105)73(119)96-53(21-14-34-91-79(86)87)66(112)95-54(30-31-59(80)109)68(114)94-52(20-13-33-90-78(84)85)67(113)100-58(76(122)123)36-45-24-28-50(108)29-25-45/h22-29,39-42,46-47,51-58,61-64,105,107-108H,5-21,30-38H2,1-4H3,(H2,80,109)(H2,81,110)(H,88,92)(H,93,106)(H,94,114)(H,95,112)(H,96,119)(H,97,115)(H,98,111)(H,99,118)(H,100,113)(H,101,116)(H,102,120)(H,103,117)(H,104,121)(H,122,123)(H4,82,83,89)(H4,84,85,90)(H4,86,87,91)/t41-,42+,51-,52-,53-,54-,55-,56-,57-,58-,61-,62-,63-,64-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
n/an/a 8n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Compound was evaluated for its inhibitory activity against Y2 receptor of rabbit kidney membrane


Bioorg Med Chem Lett 3: 937-942 (1993)


Article DOI: 10.1016/S0960-894X(00)80696-4
BindingDB Entry DOI: 10.7270/Q2H9954N
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 2


(Homo sapiens (Human))
BDBM50281778
PNG
(Ac-RHYIN-(Cha)-ITRQRY | CHEMBL415176)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O
Show InChI InChI=1S/C77H121N25O19/c1-7-39(3)59(99-68(114)53(33-43-20-24-47(105)25-21-43)95-67(113)54(35-46-37-86-38-90-46)96-63(109)49(91-42(6)104)17-12-30-87-75(80)81)70(116)97-55(36-58(79)108)69(115)102-62(45-15-10-9-11-16-45)73(119)100-60(40(4)8-2)71(117)101-61(41(5)103)72(118)94-51(19-14-32-89-77(84)85)64(110)93-52(28-29-57(78)107)66(112)92-50(18-13-31-88-76(82)83)65(111)98-56(74(120)121)34-44-22-26-48(106)27-23-44/h20-27,37-41,45,49-56,59-62,103,105-106H,7-19,28-36H2,1-6H3,(H2,78,107)(H2,79,108)(H,86,90)(H,91,104)(H,92,112)(H,93,110)(H,94,118)(H,95,113)(H,96,109)(H,97,116)(H,98,111)(H,99,114)(H,100,119)(H,101,117)(H,102,115)(H,120,121)(H4,80,81,87)(H4,82,83,88)(H4,84,85,89)/t39-,40-,41+,49-,50-,51-,52-,53-,54-,55-,56-,59-,60-,61-,62-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
n/an/a 8n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Compound was evaluated for its inhibitory activity against human neuropeptide Y2 receptor expressing LN319 cells


Bioorg Med Chem Lett 3: 937-942 (1993)


Article DOI: 10.1016/S0960-894X(00)80696-4
BindingDB Entry DOI: 10.7270/Q2H9954N
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 2


(Homo sapiens (Human))
BDBM50281778
PNG
(Ac-RHYIN-(Cha)-ITRQRY | CHEMBL415176)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O
Show InChI InChI=1S/C77H121N25O19/c1-7-39(3)59(99-68(114)53(33-43-20-24-47(105)25-21-43)95-67(113)54(35-46-37-86-38-90-46)96-63(109)49(91-42(6)104)17-12-30-87-75(80)81)70(116)97-55(36-58(79)108)69(115)102-62(45-15-10-9-11-16-45)73(119)100-60(40(4)8-2)71(117)101-61(41(5)103)72(118)94-51(19-14-32-89-77(84)85)64(110)93-52(28-29-57(78)107)66(112)92-50(18-13-31-88-76(82)83)65(111)98-56(74(120)121)34-44-22-26-48(106)27-23-44/h20-27,37-41,45,49-56,59-62,103,105-106H,7-19,28-36H2,1-6H3,(H2,78,107)(H2,79,108)(H,86,90)(H,91,104)(H,92,112)(H,93,110)(H,94,118)(H,95,113)(H,96,109)(H,97,116)(H,98,111)(H,99,114)(H,100,119)(H,101,117)(H,102,115)(H,120,121)(H4,80,81,87)(H4,82,83,88)(H4,84,85,89)/t39-,40-,41+,49-,50-,51-,52-,53-,54-,55-,56-,59-,60-,61-,62-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
n/an/a 16n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Compound was evaluated for its inhibitory activity against Y2 receptor of rabbit kidney membrane


Bioorg Med Chem Lett 3: 937-942 (1993)


Article DOI: 10.1016/S0960-894X(00)80696-4
BindingDB Entry DOI: 10.7270/Q2H9954N
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 2


(Homo sapiens (Human))
BDBM50281775
PNG
(Ac-RHYINL-(Cha)-TRQRY | CHEMBL414482)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O
Show InChI InChI=1S/C77H121N25O19/c1-7-40(4)60(100-70(116)54(33-43-19-23-47(105)24-20-43)96-67(113)55(35-46-37-86-38-90-46)97-63(109)49(91-42(6)104)16-11-29-87-75(80)81)71(117)98-56(36-59(79)108)68(114)95-53(32-39(2)3)69(115)102-62(45-14-9-8-10-15-45)73(119)101-61(41(5)103)72(118)94-51(18-13-31-89-77(84)85)64(110)93-52(27-28-58(78)107)66(112)92-50(17-12-30-88-76(82)83)65(111)99-57(74(120)121)34-44-21-25-48(106)26-22-44/h19-26,37-41,45,49-57,60-62,103,105-106H,7-18,27-36H2,1-6H3,(H2,78,107)(H2,79,108)(H,86,90)(H,91,104)(H,92,112)(H,93,110)(H,94,118)(H,95,114)(H,96,113)(H,97,109)(H,98,117)(H,99,111)(H,100,116)(H,101,119)(H,102,115)(H,120,121)(H4,80,81,87)(H4,82,83,88)(H4,84,85,89)/t40-,41+,49-,50-,51-,52-,53-,54-,55-,56-,57-,60-,61-,62-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
n/an/a 18n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Compound was evaluated for its inhibitory activity against human neuropeptide Y2 receptor expressing LN319 cells


Bioorg Med Chem Lett 3: 937-942 (1993)


Article DOI: 10.1016/S0960-894X(00)80696-4
BindingDB Entry DOI: 10.7270/Q2H9954N
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 1


(Homo sapiens (Human))
BDBM50281775
PNG
(Ac-RHYINL-(Cha)-TRQRY | CHEMBL414482)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O
Show InChI InChI=1S/C77H121N25O19/c1-7-40(4)60(100-70(116)54(33-43-19-23-47(105)24-20-43)96-67(113)55(35-46-37-86-38-90-46)97-63(109)49(91-42(6)104)16-11-29-87-75(80)81)71(117)98-56(36-59(79)108)68(114)95-53(32-39(2)3)69(115)102-62(45-14-9-8-10-15-45)73(119)101-61(41(5)103)72(118)94-51(18-13-31-89-77(84)85)64(110)93-52(27-28-58(78)107)66(112)92-50(17-12-30-88-76(82)83)65(111)99-57(74(120)121)34-44-21-25-48(106)26-22-44/h19-26,37-41,45,49-57,60-62,103,105-106H,7-18,27-36H2,1-6H3,(H2,78,107)(H2,79,108)(H,86,90)(H,91,104)(H,92,112)(H,93,110)(H,94,118)(H,95,114)(H,96,113)(H,97,109)(H,98,117)(H,99,111)(H,100,116)(H,101,119)(H,102,115)(H,120,121)(H4,80,81,87)(H4,82,83,88)(H4,84,85,89)/t40-,41+,49-,50-,51-,52-,53-,54-,55-,56-,57-,60-,61-,62-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
n/an/a 39n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Compound was evaluated for its inhibitory activity against human neuropeptide Y1 receptor expressing SK-N-MC cells


Bioorg Med Chem Lett 3: 937-942 (1993)


Article DOI: 10.1016/S0960-894X(00)80696-4
BindingDB Entry DOI: 10.7270/Q2H9954N
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 2


(Homo sapiens (Human))
BDBM50281777
PNG
(Ac-RHYINLITRQRY | CHEMBL266077)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O
Show InChI InChI=1S/C75H119N25O19/c1-9-38(5)58(98-68(114)52(31-42-17-21-45(103)22-18-42)94-65(111)53(33-44-35-84-36-88-44)95-61(107)47(89-41(8)102)14-11-27-85-73(78)79)69(115)96-54(34-57(77)106)66(112)93-51(30-37(3)4)67(113)99-59(39(6)10-2)70(116)100-60(40(7)101)71(117)92-49(16-13-29-87-75(82)83)62(108)91-50(25-26-56(76)105)64(110)90-48(15-12-28-86-74(80)81)63(109)97-55(72(118)119)32-43-19-23-46(104)24-20-43/h17-24,35-40,47-55,58-60,101,103-104H,9-16,25-34H2,1-8H3,(H2,76,105)(H2,77,106)(H,84,88)(H,89,102)(H,90,110)(H,91,108)(H,92,117)(H,93,112)(H,94,111)(H,95,107)(H,96,115)(H,97,109)(H,98,114)(H,99,113)(H,100,116)(H,118,119)(H4,78,79,85)(H4,80,81,86)(H4,82,83,87)/t38-,39-,40+,47-,48-,49-,50-,51-,52-,53-,54-,55-,58-,59-,60-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
n/an/a 160n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Compound was evaluated for its inhibitory activity against Y2 receptor of rabbit kidney membrane


Bioorg Med Chem Lett 3: 937-942 (1993)


Article DOI: 10.1016/S0960-894X(00)80696-4
BindingDB Entry DOI: 10.7270/Q2H9954N
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 2


(Homo sapiens (Human))
BDBM50281779
PNG
(CHEMBL438580 | Neuropeptide Y analogue)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
Show InChI InChI=1S/C102H162N32O24/c1-8-55(5)81(96(155)129-75(50-79(106)141)91(150)126-72(45-54(3)4)92(151)132-82(56(6)9-2)97(156)133-83(57(7)136)98(157)124-69(22-17-43-118-102(112)113)87(146)123-70(37-38-78(105)140)89(148)122-68(21-16-42-117-101(110)111)88(147)125-71(84(107)143)47-59-27-33-63(138)34-28-59)131-93(152)73(48-60-29-35-64(139)36-30-60)127-90(149)74(49-61-51-114-53-119-61)128-86(145)67(20-15-41-116-100(108)109)120-80(142)24-11-10-14-40-115-85(144)66(19-12-13-39-103)121-94(153)76(52-135)130-95(154)77-23-18-44-134(77)99(158)65(104)46-58-25-31-62(137)32-26-58/h25-36,51,53-57,65-77,81-83,135-139H,8-24,37-50,52,103-104H2,1-7H3,(H2,105,140)(H2,106,141)(H2,107,143)(H,114,119)(H,115,144)(H,120,142)(H,121,153)(H,122,148)(H,123,146)(H,124,157)(H,125,147)(H,126,150)(H,127,149)(H,128,145)(H,129,155)(H,130,154)(H,131,152)(H,132,151)(H,133,156)(H4,108,109,116)(H4,110,111,117)(H4,112,113,118)/t55-,56-,57+,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,81-,82-,83-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
n/an/a 180n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Compound was evaluated for its inhibitory activity against Y2 receptor of rabbit kidney membrane


Bioorg Med Chem Lett 3: 937-942 (1993)


Article DOI: 10.1016/S0960-894X(00)80696-4
BindingDB Entry DOI: 10.7270/Q2H9954N
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 1


(Homo sapiens (Human))
BDBM50281776
PNG
(Ac-RHYIN-(Cha)-(Cha)-TRQRY | CHEMBL268351)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O
Show InChI InChI=1S/C79H123N25O19/c1-5-41(2)61(101-70(116)55(35-44-22-26-49(107)27-23-44)97-69(115)56(37-48-39-88-40-92-48)98-65(111)51(93-43(4)106)19-12-32-89-77(82)83)72(118)99-57(38-60(81)110)71(117)103-63(46-15-8-6-9-16-46)75(121)104-64(47-17-10-7-11-18-47)74(120)102-62(42(3)105)73(119)96-53(21-14-34-91-79(86)87)66(112)95-54(30-31-59(80)109)68(114)94-52(20-13-33-90-78(84)85)67(113)100-58(76(122)123)36-45-24-28-50(108)29-25-45/h22-29,39-42,46-47,51-58,61-64,105,107-108H,5-21,30-38H2,1-4H3,(H2,80,109)(H2,81,110)(H,88,92)(H,93,106)(H,94,114)(H,95,112)(H,96,119)(H,97,115)(H,98,111)(H,99,118)(H,100,113)(H,101,116)(H,102,120)(H,103,117)(H,104,121)(H,122,123)(H4,82,83,89)(H4,84,85,90)(H4,86,87,91)/t41-,42+,51-,52-,53-,54-,55-,56-,57-,58-,61-,62-,63-,64-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
n/an/a 2.60E+4n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Compound was evaluated for its inhibitory activity against human neuropeptide Y1 receptor expressing SK-N-MC cells


Bioorg Med Chem Lett 3: 937-942 (1993)


Article DOI: 10.1016/S0960-894X(00)80696-4
BindingDB Entry DOI: 10.7270/Q2H9954N
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 1


(Homo sapiens (Human))
BDBM50281777
PNG
(Ac-RHYINLITRQRY | CHEMBL266077)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O
Show InChI InChI=1S/C75H119N25O19/c1-9-38(5)58(98-68(114)52(31-42-17-21-45(103)22-18-42)94-65(111)53(33-44-35-84-36-88-44)95-61(107)47(89-41(8)102)14-11-27-85-73(78)79)69(115)96-54(34-57(77)106)66(112)93-51(30-37(3)4)67(113)99-59(39(6)10-2)70(116)100-60(40(7)101)71(117)92-49(16-13-29-87-75(82)83)62(108)91-50(25-26-56(76)105)64(110)90-48(15-12-28-86-74(80)81)63(109)97-55(72(118)119)32-43-19-23-46(104)24-20-43/h17-24,35-40,47-55,58-60,101,103-104H,9-16,25-34H2,1-8H3,(H2,76,105)(H2,77,106)(H,84,88)(H,89,102)(H,90,110)(H,91,108)(H,92,117)(H,93,112)(H,94,111)(H,95,107)(H,96,115)(H,97,109)(H,98,114)(H,99,113)(H,100,116)(H,118,119)(H4,78,79,85)(H4,80,81,86)(H4,82,83,87)/t38-,39-,40+,47-,48-,49-,50-,51-,52-,53-,54-,55-,58-,59-,60-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
n/an/a 3.50E+4n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Compound was evaluated for its inhibitory activity against human neuropeptide Y1 receptor expressing SK-N-MC cells


Bioorg Med Chem Lett 3: 937-942 (1993)


Article DOI: 10.1016/S0960-894X(00)80696-4
BindingDB Entry DOI: 10.7270/Q2H9954N
More data for this
Ligand-Target Pair
Neuropeptide Y receptor type 1


(Homo sapiens (Human))
BDBM50281778
PNG
(Ac-RHYIN-(Cha)-ITRQRY | CHEMBL415176)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O
Show InChI InChI=1S/C77H121N25O19/c1-7-39(3)59(99-68(114)53(33-43-20-24-47(105)25-21-43)95-67(113)54(35-46-37-86-38-90-46)96-63(109)49(91-42(6)104)17-12-30-87-75(80)81)70(116)97-55(36-58(79)108)69(115)102-62(45-15-10-9-11-16-45)73(119)100-60(40(4)8-2)71(117)101-61(41(5)103)72(118)94-51(19-14-32-89-77(84)85)64(110)93-52(28-29-57(78)107)66(112)92-50(18-13-31-88-76(82)83)65(111)98-56(74(120)121)34-44-22-26-48(106)27-23-44/h20-27,37-41,45,49-56,59-62,103,105-106H,7-19,28-36H2,1-6H3,(H2,78,107)(H2,79,108)(H,86,90)(H,91,104)(H,92,112)(H,93,110)(H,94,118)(H,95,113)(H,96,109)(H,97,116)(H,98,111)(H,99,114)(H,100,119)(H,101,117)(H,102,115)(H,120,121)(H4,80,81,87)(H4,82,83,88)(H4,84,85,89)/t39-,40-,41+,49-,50-,51-,52-,53-,54-,55-,56-,59-,60-,61-,62-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
n/an/a 4.40E+4n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Compound was evaluated for its inhibitory activity against human neuropeptide Y1 receptor expressing SK-N-MC cells


Bioorg Med Chem Lett 3: 937-942 (1993)


Article DOI: 10.1016/S0960-894X(00)80696-4
BindingDB Entry DOI: 10.7270/Q2H9954N
More data for this
Ligand-Target Pair